Wenrui Hao

Director of the Center for Mathematical Biology; Professor of Mathematics


Wenrui Hao

Huck Affiliations

Links

News Articles Featuring Wenrui Hao

Four Penn State researchers receive iDEA-TECH awards from Sanofi

Four Penn State researchers and their colleagues have been awarded Innovations in Data Exploration, Analytics & Technology (iDEA-TECH) Awards from Sanofi, a global R&D-driven, artificial intelligence (AI)-powered biopharma company. The awards provide $150,000 in research funding to advance cutting-edge discoveries through novel AI and digital tools and new technologies.

From brain scans to alloys: Teaching AI to make sense of complex research data

Artificial intelligence is increasingly used to analyze medical images, materials data and scientific measurements, but many systems struggle when real-world data do not match ideal conditions. To address this issue, Penn State researchers have developed a new artificial intelligence framework with potential implications for fields ranging from Alzheimer’s disease research to advanced materials design.

Can digital replicas of patients help personalize Alzheimer’s treatment?

New NSF grant supports project to build 'digital twin' replicas of patients using clinical data to study disease progression and treatment options.

Center for Mathematical Biology appoints new director

Wenrui Hao, professor of mathematics in the Penn State Eberly College of Science and 2025-26 Huck Leadership Fellow, has been named the new director for the Center for Mathematical Biology in the Huck Institutes of the Life Sciences.

Huck announces 2025-26 Leadership Fellows

Three faculty members, representing three different Penn State colleges, have been named Huck Leadership Fellows for the 2025-26 academic year.

Penn State awards five new seed grants to support inter-institutional research

Five new research collaborations between Penn State and minority-serving institutions selected to receive seed funding via the Inter-Institutional Partnerships for Diversifying Research program.

Two Alzheimer’s drugs tested head-to-head in first-ever virtual clinical trial

An estimated 6.2 million Americans ages 65+ are living with Alzheimer's disease. The national Alzheimer's Association predicts the number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.